CPHN logo

CPH Group AG Stock Price

SWX:CPHN Community·CHF 394.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

CPHN Share Price Performance

CHF 65.80
-4.80 (-6.80%)
CHF 65.80
-4.80 (-6.80%)
Price CHF 65.80

CPHN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with solid track record.

1 Risk
4 Rewards

CPH Group AG Key Details

CHF 334.1m

Revenue

CHF 174.6m

Cost of Revenue

CHF 159.5m

Gross Profit

CHF 136.1m

Other Expenses

CHF 23.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
3.90
47.75%
6.99%
26.1%
View Full Analysis

About CPHN

Founded
1818
Employees
1244
CEO
Alois Waldburg-Zeil
WebsiteView website
cph.ch

CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland, Bosnia and Herzegovina, the USA, Canada, China, and India. The Perlen Packaging segment focuses on the pharmaceutical industry, supplying coated plastic films used primarily in blister packaging to protect medications, as well as vials and containers for medical use; and PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry. CPH Group AG was founded in 1818 and is based in Perlen, Switzerland.

Recent CPHN News & Updates

Recent updates

No updates